Location: St. Augustine

201 Health Park Blvd.

Suite #105

St. Augustine, Florida 32086

Tel: (904) 310-1845

Fax: (877) 622-0626

Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)

DELIVER Double-blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)

Location(s): St. Augustine

Condition: Heart Failure

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303

The NODE-303 Study: Multi-Centre, Multi-National,Open Label, …

Location(s): St. Augustine

Condition:

Inclisiran in Patients With Cardiovascular Disease (ORION-4)

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon, St. Augustine

Condition: Cholesterol, Heart Disease